LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway

Publication date: October 2020Source: Molecular Immunology, Volume 126Author(s): Ya-ru Yang, Fang-tian Bu, Yang Yang, Hao Li, Cheng Huang, Xiao-ming Meng, Lei Zhang, Xiong-wen Lv, Jun Li
Source: Molecular Immunology - Category: Allergy & Immunology Source Type: research